Cannabinoid Content in Cannabis Flowers and Homemade Cannabis-Based Products Used for Therapeutic Purposes in Argentina

被引:3
|
作者
Sedan, Daniela [1 ]
Vaccarini, Cristian [1 ]
Demetrio, Pablo [1 ]
Morante, Marcelo [2 ]
Montiel, Romina [3 ]
Sauri, Alvaro [3 ]
Andrinolo, Dario [1 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Natl Council Sci & Tech Res CIM UNLP, Environm Res Ctr, La Plata, Argentina
[2] La Plata Natl Univ UNLP, Med Sch, La Plata, Argentina
[3] Natl Univ Buenos Aires, UBA, Oncol Inst Angel H Roffo IOAR, Palliat Care Serv, Buenos Aires, DF, Argentina
关键词
cannabis oil; inflorescences; resins; cannabinoids; homemade herbal products; ENDOCANNABINOID SYSTEM; SATIVA; ACID;
D O I
10.1089/can.2020.0117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: A recent law (DCTO-2020-883-APN-PTE-Law No. 27,350. Regulation) passed in Argentina put an end to the ban imposed for the last 60 years on cannabis cultivation within the country. The law permits restricted access to cannabis derivatives for medicinal, therapeutic, and palliative use by individuals and communities, allowing self- and community-based cannabis production. This is cause for concern in view of the lack of quality controls for cannabis derivatives. The several varieties of cannabis grown in Argentina have different chemical profiles and are processed in a variety of ways-mostly by alcohol extraction or maceration at different temperatures and for different amounts of times-making the cannabinoid content of these preparations highly variable. Determining the characteristics of home- and community-grown cannabis products will facilitate the implementation of public policies conducive to their safety and improvement. Objective: The aim of this study was to determine the cannabinoid chemotypes used for therapeutic purposes in Argentina and evaluate whether the cannabinoids present in homemade derivatives are comparable to those in commercially available products. Materials and Methods: High performance liquid chromatography with ultraviolet and diode array detector (HPLC/UV-DAD) analysis of 436 samples (oils, resins, and inflorescences) was carried out to determine the identity and concentration of five cannabinoids: tetrahydrocannabinolic acid (THCA), tetrahydrocannabinol (THC), cannabidiolic acid (CBDA), cannabidiol (CBD), and cannabinol (CBN). From three different sources, the samples represent the type of medical cannabis preparations to which patients have access. Results: The results indicate that the medium-to-low cannabinoid concentration in a significant number of homemade oil samples is similar to that found in commercial products. Most of the samples have a THC/CBD ratio >1 or only contain THC. Acidic cannabinoids were detected in homemade preparations, but were not reported in package inserts of commercial products. Conclusions: Our results indicate that despite their considerable variability, homemade preparations as a whole show cannabinoid levels and profiles equivalent to the commercially available products commonly used for medicinal, therapeutic, and palliative purposes in Argentina.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 17 条
  • [1] DEVELOPMENT OF A METHODOLOGY FOR THE DETERMINATION OF CANNABINOIDS IN CANNABIS-BASED PRODUCTS FOR MEDICINAL PURPOSES
    Dantas, Anna S. C. L.
    Souza, Matheus N. de
    Lima, Patricia C. de
    Lima, Maria E. D.
    Santana, Daniela S.
    Maranho, Ricardo L. N.
    Colonese, Andre
    Ochs, Soraya M.
    Monteiro, Mychelle A.
    QUIMICA NOVA, 2023, 46 (03): : 282 - 289
  • [2] Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
    Martins, Ana M.
    Gomes, Ana L.
    Boas, Ines Vilas
    Marto, Joana
    Ribeiro, Helena M.
    PHARMACEUTICALS, 2022, 15 (02)
  • [3] Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability
    Baratta, Francesca
    Simiele, Marco
    Pignata, Irene
    Ravetto Enri, Lorenzo
    D'Avolio, Antonio
    Torta, Riccardo
    De Luca, Anna
    Collino, Massimo
    Brusa, Paola
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 16
  • [4] Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
    Legare, Christopher A.
    Raup-Konsavage, Wesley M.
    Vrana, Kent E.
    PHARMACOLOGY, 2022, 107 (3-4) : 131 - 149
  • [5] Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey
    Mohamed, Susan
    Lopane, Giovanna
    Sabattini, Loredana
    Scandellari, Cinzia
    Zardi, Diletta
    Donadio, Vincenzo
    Rizzo, Giovanni
    Perrone, Alessandro
    Lugaresi, Alessandra
    Contin, Manuela
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [6] Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes
    Baratta, Francesca
    Simiele, Marco
    Pignata, Irene
    Enri, Lorenzo Ravetto
    Torta, Riccardo
    De Luca, Anna
    Collino, Massimo
    D'Avolio, Antonio
    Brusa, Paola
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [7] The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
    Russo, Emilio
    Agredano, Paula Martinez
    Flachenecker, Peter
    Lawthom, Charlotte
    Munro, Duncan
    Hindocha, Chandni
    Bagul, Makarand
    Trinka, Eugen
    JOURNAL OF CANNABIS RESEARCH, 2024, 6 (01)
  • [8] An assessment of the potency related to Cannabis-based products in the South African market
    Viviers, Hendrik Jacobus
    Petzer, Anel
    Gordon, Richard
    FORENSIC SCIENCE INTERNATIONAL, 2021, 322
  • [9] Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products
    Troup, Lucy J.
    Erridge, Simon
    Ciesluk, Beata
    Sodergren, Mikael H.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)
  • [10] International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
    Haroutounian, Simon
    Arendt-Nielsen, Lars
    Belton, Joletta
    Blyth, Fiona M.
    Degenhardt, Louisa
    Di Forti, Marta
    Eccleston, Christopher
    Finn, David P.
    Finnerup, Nanna B.
    Fisher, Emma
    Fogarty, Alexandra E.
    Gilron, Ian
    Hohmann, Andrea G.
    Kalso, Eija
    Krane, Elliot
    Mohiuddin, Mohammed
    Moore, R. Andrew
    Rowbotham, Michael
    Soliman, Nadia
    Wallace, Mark
    Zinboonyahgoon, Nantthasorn
    Rice, Andrew S. C.
    PAIN, 2021, 162 : S117 - S124